Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
60.9%
% of THNR's 23 holdings also in OZEM
66.7%
% of OZEM's 22 holdings also in THNR
Overlap by Weight
Sector Drift (THNR minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in THNR |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 17.3% | 16.9% | 16.9% |
 |
NOVO-NORDISK A/S-SPONS ADR | 12.6% | 16.2% | 12.6% |
 |
ROCHE HOLDING LTD | 5.0% | 4.9% | 4.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 6.1% | 4.7% | 4.7% |
 |
INNOVENT BIOLOGICS, INC. | 5.5% | 3.6% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
THNR Overweight Relative to OZEM
|
WEST PHARMACEUTICAL SERVICES | 5.0% |
|
THERMO FISHER SCIENTIFIC INC | 4.7% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.6% |
|
MERCK & CO. INC. | 4.5% |
|
HIMS & HERS HEALTH, INC. CLASS A | 3.7% |
|
MITSUBISHI CHEMICAL HOLDINGS | 3.5% |
|
AMGEN INC | 1.9% |
|
INNOVENT BIOLOGICS, INC. | 1.8% |
 |
ASTRAZENECA PLC-SPONS ADR | 1.8% |
 |
GERRESHEIMER AG | 1.5% |
THNR Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -3.6% |
|
ALTIMMUNE, INC. | -3.4% |
|
TERNS PHARMACEUTICALS, INC. | -2.8% |
|
VIKING THERAPEUTICS, INC. | -2.6% |
 |
HANMI PHARM CO LTD | -2.5% |
|
REGENERON PHARMACEUTICALS | -2.3% |
|
ZEALAND PHARMA A/S | -2.3% |
|
SCHOLAR ROCK HOLDING CORP. | -2.2% |
 |
CHINA PHARMACEUTICAL GROUP | -2.0% |
|
SHIONOGI & CO LTD | -1.9% |